세계 중추신경계(CNS) 특이적 안티센스 올리고뉴클레오티드 시장 : 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

REPORT HIGHLIGHT

CNS Specific Antisense Oligonucleotide Market size was valued at USD 5,114 Million in 2023, expanding at a CAGR of 22.5% from 2024 to 2032.

CNS-specific antisense oligonucleotides (ASOs) are a specific type of therapeutic agent that have been designed to target and regulate gene expression within the central nervous system. These ASOs are short, single-stranded DNA or RNA molecules that have the ability to selectively bind to complementary RNA sequences. This binding process can result in a range of cellular effects, including the degradation of the targeted RNA or the modulation of its splicing. The development of CNS-specific ASOs holds great promise for the treatment of previously challenging neurological disorders. By offering a targeted approach to modulating gene expression, these molecules have the potential to address the root causes of diseases rather than simply managing their symptoms. The FDA has already approved the use of ASOs for the treatment of ten genetic diseases, and ongoing research is exploring their potential for many more.

CNS Specific Antisense Oligonucleotide Market- Market Dynamics

Increasing Prevalence of CNS Disorders is projected to drive the growth of market

CNS-specific antisense oligonucleotides present a targeted therapeutic approach in precision medicine, focusing on specific genes or pathways implicated in CNS disorders. This method holds the potential to offer more effective and safer treatment alternatives compared to broad-spectrum treatments. According to a recent United Nations report, approximately one billion individuals, accounting for nearly one in six of the global population, suffer from neurological disorders such as Alzheimer's disease, Parkinson's disease, strokes, multiple sclerosis, epilepsy, migraines, brain injuries, and neuroinfections. Tragically, these maladies claim the lives of approximately 6.8 million people annually. Moreover, ongoing advancements in drug delivery technologies and research and development investments offer promising growth opportunities for the market. However, the high costs associated with development may impede market growth.

CNS Specific Antisense Oligonucleotide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.5% over the forecast period (2024-2032)

Based on Application segmentation, Online Pharmacies was predicted to show maximum market share in the year 2023

On the basis of region, North America was the leading revenue generator in 2023

CNS Specific Antisense Oligonucleotide Market- Segmentation Analysis:

The Global CNS Specific Antisense Oligonucleotide Market is segmented on the basis of Type, Application, and Region.

The market is segmented into four classifications according to Type: Polyneuropathy Treatment, Spinal Muscular Atrophy (SMA) Treatment, and Huntington's disease Treatment. These classifications encompass various neurological conditions, and CNS-specific ASOs are currently under investigation as potential therapeutic interventions. It is crucial to acknowledge that the landscape of drug development can undergo rapid changes, and the information presented here may be subject to alteration.

The market is divided into three categories based on application: Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. The market is predominantly controlled by the Online Pharmacies segment. These digital platforms offer a convenient solution for patients to purchase prescription medications, including those used to treat neurological disorders, without the need to physically visit a traditional pharmacy.

CNS Specific Antisense Oligonucleotide Market- Geographical Insights

CNS Specific Antisense Oligonucleotide market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to the increasing demand for antisense drugs and rising healthcare expenditure. North America, particularly the United States and Canada, has advanced healthcare infrastructure, including state-of-the-art research facilities, clinical trial capabilities, and a robust regulatory framework. In 2021, the U.S. spent 17.8 percent of its gross domestic product (GDP) on healthcare, which is nearly twice the average of OECD countries, as stated in the report U.S. Health Care from a Global Perspective. Additionally, the growing demand for advanced therapeutic interventions, especially for the treatment of challenging conditions like neurodegenerative disorders, creates a favorable environment for the adoption of CNS-specific antisense oligonucleotide therapies. Furthermore, the continuous advancements in delivery technologies and the global expansion of CNS-specific antisense oligonucleotide therapies may provide growth opportunities for the market. However, regulatory challenges and safety concerns could potentially hinder the market's growth.

CNS Specific Antisense Oligonucleotide Market- Competitive Landscape:

The competitive landscape of the CNS-Specific Antisense Oligonucleotide Market has witnessed significant advancements in the biotechnology and pharmaceutical industry. These advancements have been driven by innovative strategies aimed at targeting disease-related proteins. However, the development of new drugs in this field requires a substantial investment of time, effort, and resources. Therefore, it is crucial for the market to evaluate the technological platforms utilized by different companies in the development of CNS-specific antisense oligonucleotides. Factors such as delivery methods, targeting specificity, and novel technologies play a pivotal role in this assessment. The increasing number of approved nucleic acid therapeutics further emphasizes the potential of treating diseases by targeting their genetic blueprints in vivo. Unlike conventional treatments that primarily focus on proteins, these therapeutics offer the advantage of addressing the underlying causes of diseases. One notable player in this market is Wave Life Sciences, a biotechnology company specializing in RNA therapeutics. Wave has dedicated its pipeline to CNS-specific antisense oligonucleotides, making it essential to analyze their technology platform and differentiation strategies within this context.

Recent advancements:

In October 2023, Biogen Inc. announced new Phase 1b clinical data for BIIB080, an investigational antisense oligonucleotide therapy targeting tau in mild Alzheimer's disease. The data showed promising trends in cognition and daily activities among patients with Alzheimer's disease, building upon previous results that demonstrated a reduction in tau protein levels in the cerebral spinal fluid and tau positron emission tomography across different brain regions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Akcea Therapeutics, Inc.

Ionis Pharmaceuticals Inc.

Biogen Inc.

Sarepta Therapeutics

Wave Life Sciences Ltd.

Dynacure

ProQR Therapeutics N.V.

Stroke Therapeutic Inc.

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

• Polyneuropathy Treatment
• Spinal Muscular Atrophy (SMA) Treatment
• Huntington's Disease Treatment

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. CNS Specific Antisense Oligonucleotide Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. CNS Specific Antisense Oligonucleotide Market Snippet by Type
  • 2.1.2. CNS Specific Antisense Oligonucleotide Market Snippet by Application
  • 2.1.3. CNS Specific Antisense Oligonucleotide Market Snippet by Country
  • 2.1.4. CNS Specific Antisense Oligonucleotide Market Snippet by Region
• 2.2. Competitive Insights

3. CNS Specific Antisense Oligonucleotide Key Market Trends

• 3.1. CNS Specific Antisense Oligonucleotide Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. CNS Specific Antisense Oligonucleotide Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. CNS Specific Antisense Oligonucleotide Market Opportunities
• 3.4. CNS Specific Antisense Oligonucleotide Market Future Trends

4. CNS Specific Antisense Oligonucleotide Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. CNS Specific Antisense Oligonucleotide Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. CNS Specific Antisense Oligonucleotide Market Landscape

• 6.1. CNS Specific Antisense Oligonucleotide Market Share Analysis, 2023
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. CNS Specific Antisense Oligonucleotide Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
  • 7.1.2. Polyneuropathy Treatment
  • 7.1.3. Spinal Muscular Atrophy (SMA) Treatment
  • 7.1.4. Huntington's Disease Treatment

8. CNS Specific Antisense Oligonucleotide Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2. Hospital Pharmacies
  • 8.1.3. Retail Pharmacies
  • 8.1.4. Online Pharmacies

9. CNS Specific Antisense Oligonucleotide Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.7. Italy
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.7.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.8. United Kingdom
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.9. France
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.10. Russia
    • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.10.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.11. Netherlands
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.12. Sweden
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.13. Poland
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.13.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.14. Rest of Europe
    • 9.3.14.1. Overview
    • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.8. Japan
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.9. South Korea
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- CNS Specific Antisense Oligonucleotide Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. Akcea Therapeutics, Inc.
  • 10.2.2. Ionis Pharmaceuticals Inc.
  • 10.2.3. Biogen Inc.
  • 10.2.4. Sarepta Therapeutics
  • 10.2.5. Wave Life Sciences Ltd.
  • 10.2.6. Dynacure
  • 10.2.7. ProQR Therapeutics N.V.
  • 10.2.8. Stroke Therapeutic Inc.

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us